Gleysin Cabrera

Gleysin Cabrera

Auto-generated profile, based on publicly available information

Gleysin Cabrera

Department of Carbohydrate Chemistry, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2005 in Plant Biotechnology Journal
Verified
Journal Article
Closed access
PDF file
ATAda Triguero
Ada Triguero
GCGleysin Cabrera
Gleysin Cabrera
JCJosé A. Cremata
José A. Cremata
CYChun‐Ting Yuen
Chun‐Ting Yuen
JWJun Wheeler
Jun Wheeler
NRNadia I. Ramírez
Nadia I. Ramírez

1 May 2010 in Analytical Biochemistry
Verified
Journal Article
Closed access
ATAda Triguero
Ada Triguero
GCGleysin Cabrera
Gleysin Cabrera
LRLouise Royle
Louise Royle
DHDavid J. Harvey
David J. Harvey
PRPauline M. Rudd
Pauline M. Rudd
JCJosé A. Cremata
José A. Cremata

25 June 2020 in Pathogens
Verified
Journal Article
Open access
PDF file
Alina Rodríguez MallonAlina Rodríguez Mallon
Alina Rodríguez Mallon
LGLuis Javier Gonzalez
Luis Javier Gonzalez
Pedro Enrique Encinosa GuzmánPedro Enrique Encinosa Guzmán
Pedro Enrique Encinosa Guzmán
Gervasio Henrique BecharaGervasio Henrique Bechara
Gervasio Henrique Bechara
Gustavo SanchesGustavo Sanches
Gustavo Sanches
MEMario Pablo Estrada
Mario Pablo Estrada
A synthetic 20 amino acid peptide of the ribosomal protein P0 from ticks, when conjugated to keyhole limpet hemocyanin from Megathura crenulata and used as an immunogen against Rhipicephalus microplus and Rhipicephalus sanguineus s.l. species, has shown efficacies of around 90%. There is also experimental evidence of a high efficacy of this conjugate against Amblyomma mixtum and Ixodes ricinus species, which suggest that this antigen could be a good broad-spectrum anti-tick vaccine candidate. In this study, the P0 peptide (pP0) was chemically conjugated to Bm86 as a carrier protein. SDS-PAGE analysis of this conjugate demonstrated that it is highly heterogeneous in size, carrying from 1 to 18 molecules of pP0 per molecule of Bm86. Forty-nine out of the 54 lysine residues and the N-terminal end of Bm86 were found partially linked to pP0 by using LC-MS/MS analysis and the combination of four different softwares. Several post-translational modifications of Bm86 protein were also identified by mass spectrometry. High immunogenicity and efficacy were achieved when dogs and cattle were vaccinated with the pP0–Bm86 conjugate and challenged with R. sanguineus s.l. and R. microplus, respectively. These results encourage the development of this antigen with promising possibilities as an anti-tick vaccine.
1

31 October 2006 in Current Opinion in Structural Biology
Verified
Journal Article
Closed access
MBMuriel Bardor
Muriel Bardor
GCGleysin Cabrera
Gleysin Cabrera
PRPauline M Rudd
Pauline M Rudd
RDR Dwek
R Dwek
JCJ Cremata
J Cremata
PLPatrice Lerouge
Patrice Lerouge

25 April 2008 in Analytical Biochemistry
Verified
Journal Article
Closed access
MSMartial Séveno
Martial Séveno
GCGleysin Cabrera
Gleysin Cabrera
ATAda Triguero
Ada Triguero
CBCarole Burel
Carole Burel
JLJérôme Leprince
Jérôme Leprince
MBMuriel Bardor
Muriel Bardor

25 June 2015 in Transgenic Research
Verified
Journal Article
Closed access
PDF file
AHAbel Hernández-Velázquez
Abel Hernández-Velázquez
ALAlina López-Quesada
Alina López-Quesada
YCYanaysi Ceballo-Cámara
Yanaysi Ceballo-Cámara
GCGleysin Cabrera-Herrera
Gleysin Cabrera-Herrera
KTKenia Tiel-González
Kenia Tiel-González
MPMerardo Pujol-Ferrer
Merardo Pujol-Ferrer